We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Gilead Sciences Acquires EpiTherapeutics

News   May 07, 2015

 
Gilead Sciences Acquires EpiTherapeutics
 
 
Advertisement
 

RELATED ARTICLES

Variations in Cellular Senescence May Influence Health and Onset of Age-Related Diseases

News

Researchers have proposed that cellular senescence variations during the aging process may lead to control of health and onset of age-related diseases. Based on the characteristics of the secretion of inflammatory cytokines released by aged cells, the team hypothesizes that there are at least four distinct states of cellular senescence and that these states arise from coordinated metabolic and epigenomic alterations.

READ MORE

Evidence for a DNA Methylation Signature of ASD in Cord Blood

News

A new study led by UC Davis MIND Institute researchers found a distinct DNA methylation signature in the cord blood of newborns who were eventually diagnosed with autism spectrum disorder (ASD). This signature mark spanned DNA regions and genes linked to early fetal neurodevelopment. The findings may hold clues for early diagnosis and intervention.

READ MORE

Trauma Impacts the Metabolism in Ways That Can Be Inherited, New Study Shows

News

How are signals triggered by traumatic events embedded in germ cells? A new study by Professor Isabelle Mansuy proposes a biological mechanism.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE